FindTrial
Sign In

The role of growth differentiation factor 15 in the early prediction of prognosis in acute pancreatitis: a retrospective cohort study

The role of growth differentiation factor 15 in the early prediction of prognosis in acute pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034373
Enrollment
Unknown
Registered
2020-07-03
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Gold Standard:Clinical outcome
Index test:Growth&#32
differentiation&#32
factor&#32

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Meet the diagnostic criteria for AP; 3. Onset to admission within 36 hours.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing women; 2. Patients with any history of tumor disease; 3. Patients with advanced or terminal stages of any disease.

Design outcomes

Primary

MeasureTime frame
growth differentiation factor 15;the incidence of organ failure;The incidence of local pancreatic complications;Infection rate of pancreatic necrosis;The length of stay;SEN, SPE, ACC, AUC of ROC, +LV, -LV;—

Countries

China

Contacts

Public ContactLihui Deng

West China Hospital of Sichuan University

tanout@163.com+86 1360806360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026